GSK PLC Sponsored ADR (GSK)
(Real Time Quote from BATS)
$39.92 USD
+0.06 (0.15%)
Updated Jul 29, 2024 10:34 AM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Brokerage Reports
0 items in cart
GSK PLC Sponsored ADR [GSK]
Reports for Purchase
Showing records 221 - 240 ( 252 total )
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Griffin Securities Initiates Coverage of Novelos Therapeutics
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Griffin Securities Initiates Coverage of Novelos Therapeutics
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Highly diversified product mix & geographic expansion to drive double digit earnings growth.....
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Medium-to-long term growth prospects depend on ability to record continued decent growth in emerging markets,vaccines
Provider: FIRST GLOBAL
Analyst: THOMAS K